Age and depressive symptoms change predict the 4-year self-concept trajectory for youth after anxiety treatment.


Journal

Journal of clinical psychology
ISSN: 1097-4679
Titre abrégé: J Clin Psychol
Pays: United States
ID NLM: 0217132

Informations de publication

Date de publication:
11 2022
Historique:
revised: 24 06 2022
received: 25 01 2022
accepted: 26 07 2022
pubmed: 18 8 2022
medline: 14 10 2022
entrez: 17 8 2022
Statut: ppublish

Résumé

To investigate the self-concept trajectory from before to 4 years after cognitive behavioral therapy (CBT) for youth with anxiety disorders, including predictors. Youth with anxiety diagnoses (N = 179; M = 11.5 years, SD = 2.1; 53.6% girls; 46.4% boys) received CBT in community clinics. Self-concept, anxiety/depression symptoms, and diagnostic status were assessed at pre-, post, 1-year, and 4-year posttreatment. Growth curve analyses showed that the self-concept improved significantly over time (d = 0.07 to 0.34). Higher age and a decrease in the depressive symptom trajectory predicted increased self-concept trajectory from baseline to 4 years posttreatment. Not dropping out of treatment also contributed positively to the self-concept trajectory, but not above and beyond decreased depressive symptoms. The correlation between self-concept and depressive symptoms was r = 0.60, indicating these are related but distinct. Self-concept can improve after CBT, also long-term. This change appears to primarily be associated with decreased depressive symptoms over time.

Identifiants

pubmed: 35975330
doi: 10.1002/jclp.23427
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2109-2121

Subventions

Organisme : Helse Vest

Informations de copyright

© 2022 The Authors. Journal of Clinical Psychology published by Wiley Periodicals LLC.

Références

Restor Dent Endod. 2013 Feb;38(1):52-4
pubmed: 23495371
Eur Child Adolesc Psychiatry. 2008 Aug;17(5):283-9
pubmed: 18071841
J Anxiety Disord. 2003;17(6):605-25
pubmed: 14624814
J Pers Soc Psychol. 2016 Sep;111(3):396-410
pubmed: 26692356
J Am Acad Child Adolesc Psychiatry. 2001 Aug;40(8):937-44
pubmed: 11501694
Psychol Med. 1995 Jul;25(4):755-62
pubmed: 7480452
Child Psychiatry Hum Dev. 2017 Feb;48(1):40-52
pubmed: 27209373
Child Adolesc Psychiatry Ment Health. 2017 Dec 29;11:68
pubmed: 29299058
Soc Sci Med. 2008 Mar;66(6):1429-36
pubmed: 18179852
Child Adolesc Psychiatr Clin N Am. 2011 Apr;20(2):217-38
pubmed: 21440852
Clin Psychol Rev. 2021 Feb;83:101918
pubmed: 33186776
Scand J Psychol. 2009 Feb;50(1):47-54
pubmed: 18980602
PLoS One. 2016 Nov 15;11(11):e0166116
pubmed: 27846292
Clin Psychol Rev. 2018 Aug;64:99-109
pubmed: 29526524
Psychol Med. 2012 Mar;42(3):475-84
pubmed: 21798114
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683
Behav Res Ther. 2014 Jun;57:1-12
pubmed: 24727078
Int J Environ Res Public Health. 2021 Jul 05;18(13):
pubmed: 34281121
Behav Res Ther. 1998 May;36(5):545-66
pubmed: 9648330
J Clin Psychol. 2022 Nov;78(11):2109-2121
pubmed: 35975330
J Clin Child Adolesc Psychol. 2002 Sep;31(3):335-42
pubmed: 12149971
BMC Psychol. 2021 Apr 23;9(1):59
pubmed: 33892817
Cochrane Database Syst Rev. 2020 Nov 16;11:CD013162
pubmed: 33196111
J Abnorm Child Psychol. 2009 Jul;37(5):637-52
pubmed: 19247829
Psychol Bull. 2018 Oct;144(10):1045-1080
pubmed: 30010349
Assessment. 2005 Dec;12(4):374-83
pubmed: 16244118
J Adolesc Health. 2013 Aug;53(2):287-92
pubmed: 23648133
Clin Psychol Sci. 2013 Jul;1(3):301-310
pubmed: 25541599

Auteurs

Krister W Fjermestad (KW)

Department of Psychology, University of Oslo, Oslo, Norway.

Katarina Bellika (K)

Department of Psychology, University of Oslo, Oslo, Norway.

Caroline Matre (C)

Department of Psychology, University of Oslo, Oslo, Norway.

Wendy K Silverman (WK)

Yale Child Study Centre Program for Youth Anxiety Disorders, Yale University, New Haven, Connecticut, USA.

Gro Janne Wergeland (GJ)

Åsane Child and Adolescent Mental Health Clinic, Bergen, Norway.
Haukeland University Hospital, Bergen, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH